Product Description
Paciltaxel Injection, a masterful formulation recognized as a best-seller and laureate in oncological therapeutics, receives favorable reviews worldwide for its ineffable contribution to cancer care. Available in multiple strengths (30 mg/5 ml, 100 mg/16.7 ml, 260 mg/43.4 ml), it is administered intravenously and packaged in sterile glass vials with flip-off seals. The injection, strictly for hospital use under expert medical supervision, is compatible with saline or dextrose solutions. Essential in the management of ovarian, breast, non-small cell lung cancers, and Kaposis sarcoma, Paciltaxel meets USP standards and maintains a neutral to slightly acidic pH. Ready-to-use and preservative-free, this must-have therapy comes from trusted Indian distributors and exporters.
Comprehensive Usage & Direction
Paciltaxel Injection should be delivered strictly via intravenous infusion, supervised by a healthcare professional. It is used extensively for anticancer therapy in ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposis sarcoma. It has other applications in plant research studies due to its microtubule stabilizing properties, though not for direct plant treatment. Ensure all preparation, administration, and safety protocols are followed according to prescription guidelines.
Markets, Packaging & Exchange Details
In India, Paciltaxel Injection is promptly handed over through robust supply chains to pharmacies and hospitals, ensuring safe exchange and timely delivery. It is packaged in glass vials with flip-off seals to preserve sterility. The product is actively distributed not just domestically but also to key export markets, maintaining international standards. Ample supply ability guarantees consistent availability for wholesalers, traders, and medical facilities, ensuring patient needs are met efficiently.
FAQs of Paciltaxel Injection:
Q: How is Paciltaxel Injection administered?
A: Paciltaxel Injection is administered only through intravenous (IV) infusion under strict supervision by a qualified medical oncologist within a hospital setting.
Q: What cancers does Paciltaxel Injection treat?
A: It is indicated for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposis sarcoma. Additional oncological uses may be determined by your physician.
Q: When should Paciltaxel Injection not be used?
A: This injectable therapy should not be used outside hospital environments or without supervision by a medical oncologist. Individuals with known hypersensitivity to its ingredients should avoid it.
Q: Where does Paciltaxel Injection originate from for export markets?
A: Paciltaxel Injection is distributed and exported from India by certified suppliers, wholesalers, and traders, adhering to international pharmacopeial standards.
Q: What is the process for preparing Paciltaxel Injection for use?
A: The injection must be prepared according to the manufacturers guidelines, diluted with either 0.9% sodium chloride or 5% dextrose solution before intravenous infusion.
Q: What are the possible side effects of Paciltaxel Injection usage?
A: Common side effects include neutropenia, hair loss, nausea, peripheral neuropathy, and hypersensitivity reactions. Patients should be monitored closely for these during therapy.